Two Sigma Securities’s Endovia Health Sciences, Inc. EDVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-5,530
Closed -$15.3K 2133
2025
Q4
$15.3K Buy
+5,530
New +$33.1K ﹤0.01% 1224
2025
Q1
Sell
-101
Closed -$2.59K 2100
2024
Q4
$2.59K Sell
101
-48
-32% -$1.59K ﹤0.01% 1498
2024
Q3
$6K Buy
149
+69
+86% +$3.48K ﹤0.01% 2658
2024
Q2
$2.96K Buy
80
+14
+21% +$656 ﹤0.01% 2876
2024
Q1
$4.85K Sell
66
-123
-65% -$9.8K ﹤0.01% 2841
2023
Q4
$16.7K Buy
+189
New +$18K ﹤0.01% 2750
2023
Q3
Sell
-226
Closed -$40.4K 3407
2023
Q2
$40.4K Buy
+226
New +$41.3K ﹤0.01% 2424
2022
Q1
Sell
-102
Closed -$19K 2452
2021
Q4
$19K Buy
+102
New +$27.6K ﹤0.01% 1414

Other funds holding EDVA

Two Sigma Securities's EDVA Position: Q1 2026 in Review

Two Sigma Securities sold out of Endovia Health Sciences, Inc. (EDVA) in Q1 2026, closing a stake of 5,530 shares — an estimated $15.3K sold.

Two Sigma Securities first reported a position in EDVA in Q4 2021 and held it in 8 quarters. The position peaked at $40.4K in Q2 2023. 15 funds tracked by Wall St. Rank hold EDVA as of Q1 2026.

  • Two Sigma Securities reported no remaining Endovia Health Sciences, Inc. position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Securities sold 5,530 Endovia Health Sciences, Inc. shares in Q1 2026, an estimated $15.3K.
  • Two Sigma Securities first reported a position in Endovia Health Sciences, Inc. in Q4 2021 and held it in 8 quarters.
  • Two Sigma Securities's Endovia Health Sciences, Inc. position peaked at $40.4K in Q2 2023.
  • 15 funds tracked by Wall St. Rank held Endovia Health Sciences, Inc. as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.